Anterix insider sells 122,852 shares in amended filing
Anterix Inc. insider Christopher Guttman-McCabe, Chief Reg & Comm Officer, reported multiple open-market sales of common stock on June 15, 2026 totaling 122,852 shares at weighted average prices between $78.7255 and $84.4012 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4/A
Rhea-AI Filing Summary
Anterix Inc. insider Christopher Guttman-McCabe, Chief Reg & Comm Officer, reported multiple open-market sales of common stock on June 15, 2026 totaling 122,852 shares at weighted average prices between $78.7255 and $84.4012 per share. A Form 4/A amendment corrects the originally reported amounts, reflecting an additional 31,415 shares sold and revised beneficial ownership figures.
Insider Trade Summary
Net Seller: 122,852 shares
Net Sell
7 txns
Insider
Guttman-McCabe Christopher
Role
Chief Reg & Comm Officer
Sold
122,852 shs ($10.04M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 11,668 | $78.7255 | $919K |
| Sale | Common Stock F3, F2 | 5,030 | $79.5296 | $400K |
| Sale | Common Stock F4, F2 | 21,434 | $80.6322 | $1.73M |
| Sale | Common Stock F5, F2 | 34,870 | $81.5097 | $2.84M |
| Sale | Common Stock F6, F2 | 21,045 | $82.3878 | $1.73M |
| Sale | Common Stock F7, F2 | 21,050 | $83.8596 | $1.77M |
| Sale | Common Stock F8, F2 | 7,755 | $84.4012 | $655K |
Holdings After Transaction:
Common Stock — 46,392 shares (Direct)
Footnotes (8)
- F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.07 to $79.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F2. This Form 4/A amends the Form 4 filed by the reporting person on June 17, 2026 (the "Original Form 4"), which due to a clerical error inadvertently reported the incorrect number of securities sold in column 4 of Table I and the amount of shares beneficially owned in column 5 of Table I. This Form 4/A is being filed solely to correct the number of securities reported in column 4 and column 5 of Table II to reflect that an additional 31,415 shares were sold. No other amendments or changes have been made to the Original Form 4, except as reported in the Form 4/A filed by the Reporting Person on July 10, 2026.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.085 to $80.035, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.085 to $81.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.09 to $82.035, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.14 to $83.095, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.225 to $84.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.23 to $84.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
Key Figures
Total shares sold: 122,852 shares
Number of sale transactions: 7
Weighted average sale price: $78.7255 per share
+3 more
6 metrics
Total shares sold
122,852 shares
Aggregate common stock sales by Christopher Guttman-McCabe on June 15, 2026
Number of sale transactions
7
Separate open-market sales of Anterix common stock on June 15, 2026
Weighted average sale price
$78.7255 per share
One of the reported weighted average prices for the June 15, 2026 sales
Highest weighted average price
$84.4012 per share
Highest weighted average sale price reported among the June 15, 2026 transactions
Additional shares sold on correction
31,415 shares
Extra shares the amendment states were sold beyond the original Form 4 report
Sell count
7
SellCount from transaction summary indicating all reported transactions were sales
Key Terms
weighted average price, Form 4/A, beneficially owned, open market or private transaction
4 terms
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Form 4/A regulatory
"This Form 4/A amends the Form 4 filed by the reporting person"
Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.
beneficially owned financial
"reported the incorrect number of securities sold ... and the amount of shares beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
open market or private transaction financial
"Sale in open market or private transaction"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Anterix Inc. (ATEX) report in this Form 4/A?
Anterix Inc. reported that officer Christopher Guttman-McCabe sold 122,852 shares of common stock on June 15, 2026. The sales occurred in multiple open-market transactions at various weighted average prices disclosed in the amendment.
Why was this Anterix Inc. (ATEX) filing submitted as a Form 4/A amendment?
The filing is a Form 4/A amendment to correct a prior Form 4 that contained clerical errors in the number of securities sold and the amount of shares beneficially owned. It also reflects that an additional 31,415 shares were sold.
What price ranges applied to the Anterix Inc. (ATEX) insider stock sales in this Form 4/A?
The reported sales used weighted average prices, with per-share values including $78.7255, $79.5296, $80.6322, $81.5097, $82.3878, $83.8596, and $84.4012. Footnotes state each average covers multiple trades within specified price ranges.
Does this Anterix Inc. (ATEX) Form 4/A mention a Rule 10b5-1 trading plan?
The filing indicates the Rule 10b5-1 checkbox is not marked as affirming a trading plan. The footnotes describe weighted average prices and a correction to prior reporting, but do not state that these transactions were made under a Rule 10b5-1 plan.
What specific correction does the Anterix Inc. (ATEX) Form 4/A make to the original Form 4?
The amendment states the original Form 4 inadvertently reported incorrect securities sold and beneficially owned amounts. It corrects column 4 and column 5 entries and clarifies that an additional 31,415 shares were sold beyond what was first reported.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates